Upgrade to MarketBeat All Access to add more stocks to your watchlist. Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat’s FREE daily newsletter. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time. This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.

JSI and Jiko Bank are not affiliated with Public Holdings, Inc. (“Public”) or any of its subsidiaries. None of these entities provide legal, tax, or accounting advice. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. https://1investing.in/ This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.32% per year. These returns cover a period from January 1, 1988 through July 31, 2023.

For Business

Our Quantitative Research team models direct competitors or comparable companies
from a bottom-up perspective to find companies describing their business in a
similar fashion.

• A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
• It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine.
• All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.
• As an investor, you want to buy stocks with the highest probability of success.
• The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security.

Banking services and bank accounts are offered by Jiko Bank, a division of Mid-Central National Bank, Member FDIC. The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest.

About Microbot Medical Inc.

Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. Professor Francois H. Cornelis is a world renown neuro interventional radiologist who specializes in minimally invasive image-guided therapies Professor Francois H. Cornelis is a world renown neuro in… Microbot Medical’s stock is owned by a variety of retail and institutional investors. The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.

Compare
MBOT’s historical performance
against its industry peers and the overall market. When you see MBOT stock appear in the results, tap it to open up the purchase screen. There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. Provides a general description of the business conducted by this company.

ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Shares of Microbot Medical reverse split on Monday, May 9th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Microbot Medical Inc

0 equities research analysts have issued twelve-month price objectives for Microbot Medical’s shares. On average, they anticipate the company’s share price to reach $8.00 in the next year. This suggests a possible upside of 277.4% from the stock’s current price. View analysts price targets for MBOT or view top-rated stocks among Wall Street analysts. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

You can find your newly purchased MBOT stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets. According to one analyst, the rating for MBOT stock is “Strong Buy” and the 12-month stock price forecast is $8.0. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. Shares of medical device company Microbot Medical Inc. shot up 89% on Tuesday after it said it had validated the operational effectiveness of a self-cleaning shunt for treatment of hydrocephalus in an independent in-vitro…

Financials

Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes.

It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. One share of MBOT stock can currently be purchased for approximately $2.12. Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates. MBOT’s beta can be found in Trading Information at the top of this page. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Account

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction. Microbot Medical, the innovator behind the groundbreaking LIBERTY® Surgical Robotic System, has announced triumphant results from a comprehensive pre-clinical animal study conducted at a renowned European… The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries.

For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, c2c meaning until an offering statement filed with the SEC has been qualified by the SEC. An indication of interest to purchase securities involves no obligation or commitment of any kind. Microbot Medical Inc. shares slid 24% Friday, after the medical device company announced a $10 million registered direct offering priced at-the-market at $10.50, a discount to its closing price Thursday of $13.98.

H.C. Wainwright Keeps Their Buy Rating on Microbot Medical (MBOT)

Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security.

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.